[セプシスに関連した伝播性血管内凝固]

Ema Hashiguchi¹, Takashi Ito²

¹Medical Laboratory Sciences, School of Medicine, Kumamoto University.

[Rinsho ketsueki] The Japanese journal of clinical hematology

|September 3, 2025

まとめ

セプシスとは感染による臓器機能障害で血液の凝固が前血栓状態に変化します抗凝固治療は,抗血栓剤と同様に,セプシスに関連した拡散性血管内凝固 (DIC) と臓器損傷の管理に役立ちます.

科学分野:

クリティカルケア医療
血液学
感染症

背景:

感染に対する宿主体の反応が調節されていないため,生命を脅かす臓器機能障害です.
伝染病は前血栓/抗血栓のバランスを前血栓状態,つまり防御メカニズムにシフトさせることができます
重篤な感染症における未抑制のプロトロンボティック反応は,セプシスに関連した拡散性血管内凝固 (DIC) と臓器損傷を引き起こす.

研究の目的:

セプシスに関連したDICの管理における抗凝固剤の役割を見直す.
セプシスとDICの管理に関する現在の日本の臨床実務ガイドラインを強調する.
セプシスにおける最適の抗凝固戦略に関するさらなる議論の場を特定する.

主な方法:

現在の文献と臨床実務ガイドラインのレビュー
セプシスに関連したDICの病理学的分析
セプシスに関連したDICの治療勧告の評価

主要な成果:

セプシスに関連したDICは,広範囲の缺血臓器損傷を含みます.
抗凝固療法により,結血症に関連したDICにおける血栓性臓器損傷を緩和することができる.
日本ガイドラインは,抗血栓または再結合血栓モジュリンをセプスに関連したDICに推奨しています.

結論:

抗凝固薬はセプシスに関連したDICの潜在的な治療戦略です.
現在のガイドラインでは,特定の治療薬が推奨されています.
セプシスに関連したDICにおける抗凝固剤の患者選択と治療法を最適化するために,さらなる研究が必要である.

キーワード:

アンチトロンビン免疫血栓症セプシストロンボモジュリン

さらに関連する動画

07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

10.1K

05:28

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

3.7K

関連する概念動画

01:24

Disorders of Hemostasis

1.2K

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

1.2K

01:20

Extrinsic and Intrinsic Pathways of Hemostasis

9.2K

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

9.2K

01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...

01:09

Coagulation

7.4K

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

7.4K

01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...

01:05

Introduction to Hemostasis

8.9K

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...